Researchers have presented clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, also helps people to quit smoking marijuana (cannabis). Unlike…

A group of neuroscientists and ethicists have recently published a paper warning about the perils of the use of pharmacological drugs for cognitive enhancement by healthy individuals. The paper can…

Keryx Biopharmaceuticals, Inc. , announced today that its Japanese partner, Japan Tobacco Inc. (JT) and Torii Pharmaceutical Co., Ltd. (Torii), has announced positive top-line results from a Phase 3…

ONO-4641, an investigational oral drug, reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented this week at…

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for ferumoxytol, a new intravenous (IV) iron therapy with a proposed…

Synairgen plc , announces positive data from its Phase II clinical trial. This pioneering trial investigated the potential for SNG001 (inhaled interferon beta) to protect asthmatics from respiratory…

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will present final data from a Phase 2a trial showing that…

Abbott and Enanta Pharmaceuticals announced data from "Co-Pilot," an interferon-free, Phase 2 study of Abbott's direct-acting antiviral medicines for the treatment of hepatitis C (HCV) that found…

  Abbott and Enanta Pharmaceuticals announced complete data from the study known as "Pilot" - Abbott's initial interferon-free study of its direct-acting antiviral agents for the treatment of…

Evidence suggests that eating blueberries, blackberries, strawberries and other berry fruits has beneficial effects on the brain and may help prevent age-related memory loss and other changes,…